Compounders Research Compare

Kura Oncology, Inc.(KURA)

Biotechnology · San Diego, CA

$10.53-0.09 (-0.85%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Kura Oncology, Inc.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.

San Diego, CA

260 employees

kuraoncology.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Troy Wilson

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T20:37:07.592Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:37:07.592Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -3.37
Quote price: 10.53

FMP input reference: 19f1946388931e4ee5326c5171249fc23a65b0c9e42408d49e268755c1a57655

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

KURA Earnings Yield Metrics

EARNINGS YIELD

N/A

KURA Competitors' Earnings Yield

Kura Oncology, Inc.

Current

Market Cap

$934.79M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Seaport Therapeutics, Inc. Common Stock

Market Cap

$929.83M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CeriBell, Inc.

Market Cap

$923.53M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MoonLake Immunotherapeutics

Market Cap

$921.06M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Savara Inc.

Market Cap

$952.91M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aktis Oncology, Inc.

Market Cap

$953.81M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HealthStream, Inc.

Market Cap

$914.73M

Earnings Yield

2.28%

TTM Avg

2.73%

3Y Avg

2.26%

5Y Avg

1.85%

Pacira BioSciences, Inc.

Market Cap

$973.93M

Earnings Yield

1.42%

TTM Avg

1.18%

3Y Avg

2.75%

5Y Avg

2.30%

Latigo Biotherapeutics Inc.

Market Cap

$978.09M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Corvus Pharmaceuticals, Inc.

Market Cap

$887.99M

Earnings Yield

N/A

TTM Avg

2.57%

3Y Avg

2.57%

5Y Avg

2.57%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Kura Oncology, Inc. (KURA)	$934.79M	N/A	N/A	N/A	N/A
Seaport Therapeutics, Inc. Common Stock (SPTX)vs ›	$929.83M	N/A	N/A	N/A	N/A
CeriBell, Inc. (CBLL)vs ›	$923.53M	N/A	N/A	N/A	N/A
MoonLake Immunotherapeutics (MLTX)vs ›	$921.06M	N/A	N/A	N/A	N/A
Savara Inc. (SVRA)vs ›	$952.91M	N/A	N/A	N/A	N/A
Aktis Oncology, Inc. (AKTS)vs ›	$953.81M	N/A	N/A	N/A	N/A
HealthStream, Inc. (HSTM)vs ›	$914.73M	2.28%	2.73%	2.26%	1.85%
Pacira BioSciences, Inc. (PCRX)vs ›	$973.93M	1.42%	1.18%	2.75%	2.30%
Latigo Biotherapeutics Inc. (LTGO)vs ›	$978.09M	N/A	N/A	N/A	N/A
Corvus Pharmaceuticals, Inc. (CRVS)vs ›	$887.99M	N/A	2.57%	2.57%	2.57%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics